Výsledky vyhledávání - "Aslak Rautio"

The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial

Autor: Linda Mellbin, Kurt Boman, Shun Fu Lee, Hertzel C. Gerstein, Jenny Hernestål-Boman, Aslak Rautio, Mona Olofsson

Publikováno v: Diabetes and Vascular Disease Research. 14:345-352

Introduction: Fibrinolytic factors, plasminogen activator inhibitor-1, tissue plasminogen activator, tissue plasminogen activator/plasminogen activator-complex and the haemostatic factor von Willebrand factor are known markers of cardiovascular disea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::001870c09e7d27222b80f3f8d485dfc1
https://doi.org/10.1177/1479164117703034

Zobrazit plný text záznamu

Markers of fibrinolysis may predict development of lower extremity arterial disease in patients with diabetes: A longitudinal prospective cohort study with 10 years of follow-up

Autor: Aslak Rautio, Kurt Boman, Jan W. Eriksson, Maria Svensson

Publikováno v: Diabetesvascular disease research. 13(3)

Background: A previous cross-sectional study suggested that tissue plasminogen activator–activity might be an early marker of asymptomatic lower extremity arterial disease, but the long-term relationship is unknown. Subjects and methods: This study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daeb7c1e378e5ae861edce4d4640ee98
https://pubmed.ncbi.nlm.nih.gov/26818227

Zobrazit plný text záznamu

Low level of tissue plasminogen activator activity in non-diabetic patients with a first myocardial infarction

Autor: B Dinesen, Michael E Røder, Mats Eliasson, Dan Lundblad, Aslak Rautio

Publikováno v: Journal of Internal Medicine. 258:13-20

To explore the role of tissue plasminogen activator (tPA) activity and plasminogen activator inhibitor type 1 (PAI-1) in survivors of a first myocardial infarction (MI). Insulin and proinsulin were analysed as potential risk factors.Case-control stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9234a29ba15ce1e29c2a96ee96666e3
https://doi.org/10.1111/j.1365-2796.2005.01507.x

Zobrazit plný text záznamu

Favorable trends in the incidence and outcome in stroke in nondiabetic and diabetic subjects: findings from the Northern Sweden MONICA Stroke Registry in 1985 to 2003

Autor: Mats Eliasson, Birgitta Stegmayr, Aslak Rautio

Publikováno v: Stroke. 39(12)

Background and Purpose— Several studies indicate a declining case-fatality and mortality in stroke. Little is known about time trends in stroke for subjects with diabetes. The purpose of this study was to compare time trends in incidence, case-fata

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5321ac9f1f6b09bf38c6de7d8858a0ee
https://pubmed.ncbi.nlm.nih.gov/18723426

Zobrazit plný text záznamu

Favourable trends in the incidence and outcome of myocardial infarction in nondiabetic, but not in diabetic, subjects: findings from the MONICA myocardial infarction registry in northern Sweden in 1989-2000

Autor: Birgitta Stegmayr, Torbjörn Messner, Aslak Rautio, Mats Eliasson, Vivan Lundberg, Salmir Nasic

Publikováno v: Journal of internal medicine. 258(4)

The aim of this study was to compare time trends in incidence, case fatality and mortality due to myocardial infarction (MI) in patients with or without diabetes.This study was based on the Northern Sweden MONICA Project MI registry with a target pop

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efe63210b4aa5a6854eaf3b5aa95ac47
https://pubmed.ncbi.nlm.nih.gov/16164577

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání